Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans

被引:41
作者
Couch, Robert B. [1 ]
Decker, William K. [2 ]
Utama, Budi [1 ]
Atmar, Robert L. [1 ,3 ]
Nino, Diane [1 ]
Feng, Jing Qi [4 ]
Halpert, Matthew M. [2 ]
Air, Gillian M. [4 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
PHASE-I; SUBUNIT VACCINES; A/H5N1; VACCINE; CLINICAL-TRIAL; SPLIT-VIRION; SAFETY; VIRUS; WHOLE; HEMAGGLUTININ; CANDIDATE;
D O I
10.1371/journal.pone.0050830
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Serum antibody responses in humans to inactivated influenza A (H5N1), (H9N2) and A (H7) vaccines have been varied but frequently low, particularly for subunit vaccines without adjuvant despite hemagglutinin (HA) concentrations expected to induce good responses. Design: To help understand the low responses to subunit vaccines, we evaluated influenza A (H5N1), (H9N2), (H7N7) vaccines and 2009 pandemic (H1N1) vaccines for antigen uptake, processing and presentation by dendritic cells to T cells, conformation of vaccine HA in antibody binding assays and gel analyses, HA titers with different red blood cells, and vaccine morphology in electron micrographs (EM). Results: Antigen uptake, processing and presentation of H5, H7, H9 and H1 vaccine preparations evaluated in humans appeared normal. No differences were detected in antibody interactions with vaccine and matched virus; although H7 trimer was not detected in western blots, no abnormalities in the conformation of the HA antigens were identified. The lowest HA titers for the vaccines were <1:4 for the H7 vaccine and 1: 661 for an H9 vaccine; these vaccines induced the fewest antibody responses. A (H1N1) vaccines were the most immunogenic in humans; intact virus and virus pieces were prominent in EM. A good immunogenic A (H9N2) vaccine contained primarily particles of viral membrane with external HA and NA. A (H5N1) vaccines intermediate in immunogenicity were mostly indistinct structural units with stellates; the least immunogenic A (H7N7) vaccine contained mostly small 5 to 20 nm structures. Summary: Antigen uptake, processing and presentation to human T cells and conformation of the HA appeared normal for each inactivated influenza A vaccine. Low HA titer was associated with low immunogenicity and presence of particles or split virus pieces was associated with higher immunogenicity. Citation: Couch RB, Decker WK, Utama B, Atmar RL, Nino D, et al. (2012) Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans. PLoS ONE 7(12): e50830. doi:10.1371/journal.pone.0050830
引用
收藏
页数:13
相关论文
共 56 条
[1]   Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations [J].
Atmar, Robert L. ;
Keitel, Wendy A. ;
Patel, Shital M. ;
Katz, Jacqueline M. ;
She, Dewei ;
El Sahly, Hana ;
Pompey, Justine ;
Cate, Thomas R. ;
Couch, Robert B. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) :1135-1142
[2]   Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant [J].
Belshe, Robert B. ;
Frey, Sharon E. ;
Graham, Irene ;
Mulligan, Mark J. ;
Edupuganti, Srilatha ;
Jackson, Lisa A. ;
Wald, Anna ;
Poland, Gregory ;
Jacobson, Robert ;
Keyserling, Harry L. ;
Spearman, Paul ;
Hill, Heather ;
Wolff, Mark .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (05) :666-673
[3]   Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults [J].
Bernstein, David I. ;
Edwards, Kathryn M. ;
Dekker, Cornelia L. ;
Belshe, Robert ;
Talbot, Helen K. B. ;
Graham, Irene L. ;
Noah, Diana L. ;
He, Fenhua ;
Hill, Heather .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05) :667-675
[4]   Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial [J].
Bresson, Jean-Louis ;
Perronne, Christian ;
Launay, Odile ;
Gerdil, Catherine ;
Saville, Melanie ;
Wood, John ;
Hoeschler, Katja ;
Zambon, Maria C. .
LANCET, 2006, 367 (9523) :1657-1664
[5]   Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine. [J].
Clark, Tristan W. ;
Pareek, Manish ;
Hoschler, Katja ;
Dillon, Helen ;
Nicholson, Karl G. ;
Groth, Nicola ;
Stephenson, Iain .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2424-2435
[6]  
Couch RB, 2012, PLOS ONE IN PRESS
[7]   Seasonal inactivated influenza virus vaccines [J].
Couch, Robert B. .
VACCINE, 2008, 26 :D5-D9
[8]  
Couch RB, 2011, BIRKHAUSER ADV INFEC, P359, DOI 10.1007/978-3-0346-0279-2_15
[9]   A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine [J].
Cox, Rebecca J. ;
Madhun, Abdullah S. ;
Hauge, Solveig ;
Sjursen, Haakon ;
Major, Diane ;
Kuhne, Mirjam ;
Hoeschler, Katja ;
Saville, Melanie ;
Vogel, Frederick R. ;
Barclay, Wendy ;
Donatelli, Isabella ;
Zambon, Maria ;
Wood, John ;
Haaheim, Lars R. .
VACCINE, 2009, 27 (13) :1889-1897
[10]   Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help [J].
Decker, WK ;
Xing, DX ;
Li, SF ;
Robinson, SN ;
Yang, H ;
Yao, X ;
Segall, H ;
McMannis, JD ;
Komanduri, KV ;
Champlin, RE ;
Shpall, EJ .
VACCINE, 2006, 24 (16) :3203-3216